A Novel Case Report of CD5-Negative Mantle Cell Lymphoma Presenting in the Oral Cavity

Madison E. Richards; Scarlet Charmelo-Silva; Allison Buchanan; Natasha M. Savage; Rafik A. Abdelsayed

doi:10.5327/2525-5711.490

Autores/as

Madison E. Richards Augusta University, Dental College of Georgia, Department of Oral Health & Diagnostic Sciences – Augusta (GA), United States of America. https://orcid.org/0009-0007-1874-7742
Scarlet Charmelo-Silva Augusta University, Dental College of Georgia, Department of Oral Health & Diagnostic Sciences – Augusta (GA), United States of America. https://orcid.org/0009-0006-8132-3937
Allison Buchanan Augusta University, Dental College of Georgia, Department of Oral Health & Diagnostic Sciences – Augusta (GA), United States of America. https://orcid.org/0009-0001-7444-4590
Natasha M. Savage Augusta University, Medical College of Georgia, Pathology – Augusta (GA), United States of America. https://orcid.org/0000-0003-1474-9568
Rafik A. Abdelsayed Augusta University, Dental College of Georgia, Department of Oral Health & Diagnostic Sciences – Augusta (GA), United States of America. https://orcid.org/0009-0008-4098-2391

DOI:

https://doi.org/10.5327/2525-5711.490%20

Palabras clave:

Mantle Cell Lymphoma, Mouth Neoplasms, Head and Neck Cancer, Diagnostic Imaging, Immunohistochemistry

Resumen

Proliferating lymphoid cells in lymphoma have the potential to involve not only lymph nodes, but other lymphoid tissues (including those in the oral cavity). This case represents a very rare diagnostic entity: oral extranodal presentation of CD5-negative Mantle cell lymphoma. In asymptomatic palatal swellings in adults, this uncommon variant of lymphoma should be considered in the differential diagnosis because early detection and treatment improve patient outcomes.

Citas

1. Jamil A, Mukkamalla SKR. Lymphoma. In: StatPearls. Treasure Island: StatPearls Publishing; 2026. PMID: 32809661.

2. Jain P, Wang M. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol. 2019;94(6):710-25. https://doi.org/10.1002/ajh.25487

3. Vose JM. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2015;90(8):739-45. https://doi.org/10.1002/ajh.24094

4. Marcucci M, Marcucci G, Cordeiro MS, León JE, Araujo JP, Oliveira JX, et al, Mantle cell lymphoma: involvement of nodal and extranodal sites in the head and neck, with multifocal oral lesions. Autops Case Rep. 2017;7(3):26-31. https://doi.org/10.4322/acr.2017.030

5. Soleimani A, Schmieg JJ, Brown TC, Yin L, Safah H, Saba NS. CD5-negative mantle cell lymphoma defines a distinct disease entity characterized by an indolent clinical course irrespective of known prognostic markers. Blood. 2017;130(Supplement 1):4061. https://doi.org/10.1182/blood.V130.Suppl_1.4061.4061

6. Muscelli S, Shah SS, Bigcas JL. Extranodal manifestation of mantle cell lymphoma in the submandibular duct: a case report and review of the literature. Otolaryngol Case Rep. 2023;26:100498.

7. Rayess HM, Nissan M, Gupta A, Carron MA, Naweed Raza S, Fribley AM. Oropharyngeal lymphoma: a US population based analysis. Oral Oncol. 2017;73:147-51. https://doi.org/10.1016/j.oraloncology.2017.08.018

8. Lynch DT, Koya S, Dogga S, Kumar A. Mantle cell lymphoma. In: StatPearls. Treasure Island: StatPearls Publishing; 2026. PMID: 30725670.

9. Navarro A, Beà S, Jares P, Campo E. Molecular pathogenesis of mantle cell lymphoma. Hematol Oncol Clin North Am. 2020;34(5):795-807. https://doi.org/10.1016/j.hoc.2020.05.002

10. Zhang XM, Aguilera N. New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma. Arch Pathol Lab Med. 2014;138(12):1666-72. https://doi.org/10.5858/arpa.2014-0058-RA

11. Wang HY, Zu Y. Diagnostic algorithm of common mature B-Cell lymphomas by immunohistochemistry. Arch Pathol Lab Med. 2017;141(9):1236-46. https://doi.org/10.5858/arpa.2016-0521-RA

12. Gonçalves MWA, Lavareze L, Chone CT, Egal ESA, Altemani A, Mariano FV, et al. Mantle cell lymphoma in the oral cavity: exploring the differential microscopic diagnosis of a rare case. Indian J Otolaryngol Head Neck Surg. 2024;76(5):4806-9. https://doi.org/10.1007/s12070-024-04859-6

13. Wagner VP, Rodrigues-Fernandes CI, Carvalho MVR, Santos JN, Barra MB, Hunter KD, et al. Mantle cell lymphoma, malt lymphoma, small lymphocytic lymphoma, and follicular lymphoma of the oral cavity: an update. J Oral Pathol Med. 2021;50(6):622-30. https://doi.org/10.1111/jop.13214

14. Carvalho MVR, Rodrigues-Fernandes CI, Cáceres CVBL, Mesquita RA, Martins MD, Tager EMJR, et al. Mantle cell lymphoma involving the oral and maxillofacial region: a study of 20 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;135(1):101-9. https://doi.org/10.1016/j.oooo.2022.08.018

15. Miao Y, Lin P, Saksena A, Xu J, Wang M, Romaguera J, et al. CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 patients. Am J Surg Pathol. 2019;43(8):1052-60. https://doi.org/10.1097/PAS.0000000000001278

16. Soleimani A, Navarro A, Liu D, Herman SEM, Chuang SS, Slavutsky I, et al. CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage. Leuk Lymphoma. 2022;63(4):911-7. https://doi.org/10.1080/10428194.2021.2002317

17. Jerkeman M, Aurer I, Campo E, Cheah CY, Clark J, Doorduijn J, et al. EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma. Hemasphere. 2025;9(10):e70233. https://doi.org/10.1002/hem3.70233

18. Barraclough A, Hawkes E, Sehn LH, Smith SM. Diffuse large B-cell lymphoma. Hematol Oncol. 2024;42(6):e3202. https://doi.org/10.1002/hon.3202

19. Silkenstedt E, Dreyling M. Mantle cell lymphoma-update on molecular biology, prognostication and treatment approaches. Hematol Oncol. 2023;41 Suppl 1:36-42. https://doi.org/10.1002/hon.3149